VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $649,000 | -39.1% | 3,640 | -24.2% | 0.06% | -4.8% |
| Q2 2015 | $1,066,000 | +3.2% | 4,800 | -7.7% | 0.06% | -6.0% |
| Q1 2015 | $1,033,000 | +55.6% | 5,200 | +12.1% | 0.07% | +52.3% |
| Q4 2014 | $664,000 | +4.7% | 4,640 | -3.9% | 0.04% | 0.0% |
| Q3 2014 | $634,000 | -48.7% | 4,830 | -50.7% | 0.04% | -48.2% |
| Q2 2014 | $1,235,000 | -88.8% | 9,795 | -88.3% | 0.08% | -89.5% |
| Q1 2014 | $11,075,000 | -4.1% | 84,011 | -14.6% | 0.81% | -5.8% |
| Q4 2013 | $11,549,000 | +22.0% | 98,376 | +8.4% | 0.86% | +10.7% |
| Q3 2013 | $9,465,000 | -9.3% | 90,726 | -25.2% | 0.78% | -15.7% |
| Q2 2013 | $10,439,000 | – | 121,276 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |